Technically true, but completely misrepresents the issue.
Discovering (100s of)compounds in a lab (which is what the public funds pay for) is the easy and much cheaper part.
Testing it in humans and modifying it for that purpose is hard, expensive, and time consuming. Pretending like these drug companies do nothing and just take all the benefit from public research is incorrect.
I never said they did nothing. I'm pointing out that they aren't the John Galt story that people are lead to believe when people mention "recouping cost". And like any other shareholder, shouldn't we see something of a benefit for putting up our own capital?
Here on HN, we should easily be able to see through this trope. The government made a $37.5 million grant to study a range of drugs. How much equity should the government get for what basically amounts to seed funding for the $1 billion cost of bringing a drug to market? (Account for dilution and the fact that the “investor” here doesn’t put more money into subsequent funding rounds.)
Comments
Remdesivir was developed with public funds. Shouldn't the fact that the public shouldered the risk of development be factored into any of this?
https://www.uab.edu/news/health/item/11082-investigational-c...
Technically true, but completely misrepresents the issue.
Discovering (100s of)compounds in a lab (which is what the public funds pay for) is the easy and much cheaper part.
Testing it in humans and modifying it for that purpose is hard, expensive, and time consuming. Pretending like these drug companies do nothing and just take all the benefit from public research is incorrect.
I never said they did nothing. I'm pointing out that they aren't the John Galt story that people are lead to believe when people mention "recouping cost". And like any other shareholder, shouldn't we see something of a benefit for putting up our own capital?
Here on HN, we should easily be able to see through this trope. The government made a $37.5 million grant to study a range of drugs. How much equity should the government get for what basically amounts to seed funding for the $1 billion cost of bringing a drug to market? (Account for dilution and the fact that the “investor” here doesn’t put more money into subsequent funding rounds.)
That's a good point.